跳至主要内容
临床试验/NCT07573852
NCT07573852已完成不适用

A Retrospective Cohort Study of Multimodal Electrocardiography and Chest Radiography for Prediction of Progression to Moderate or Severe Regurgitant Valvular Heart Disease

Shanghai Zhongshan Hospital1 个研究点 分布在 1 个国家目标入组 116,380 人开始时间: 2017年7月14日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
116,380
试验地点
1

研究概览

简要总结

This retrospective multicenter cohort study aims to develop and validate an artificial intelligence model integrating electrocardiography (ECG) and chest radiography (CXR) to predict future progression of regurgitant valvular heart disease (rVHD), including aortic, mitral, and tricuspid regurgitation. Adult patients with ECG, CXR, and echocardiography obtained within 60 days, together with follow-up echocardiographic data, are included. The primary objective is to determine whether multimodal ECG+CXR modeling improves prediction of progression to moderate or severe regurgitation beyond ECG-only or CXR-only models. Secondary objectives include evaluation of clinical utility, risk stratification, and model interpretability. This study is intended to assess whether routinely acquired ECG and CXR can be used to support surveillance echocardiography and risk-directed management in patients at risk of future rVHD progression.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients aged ≥18 years. Underwent routine electrocardiography (ECG), chest radiography (CXR), and echocardiography within 60 days.
  • Had subsequent follow-up echocardiographic data available for outcome ascertainment.
  • Patients were identified from routine clinical practice in inpatient admission or outpatient evaluation settings.

排除标准

  • Age below the adult threshold. Missing any of the required baseline examinations (ECG, CXR, or echocardiography within 60 days).
  • No follow-up echocardiographic data available. For future-risk evaluation in the test cohort, samples with moderate or severe regurgitation at baseline were excluded.

研究者

发起方
Shanghai Zhongshan Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验